|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.59 BRL | +2.63% |
|
-0.56% | -23.02% |
| 11:33am | MLCC Prices Surge as AI Supply Chain Faces New Bottleneck |  |
| 06-30 | Eli Lilly, Regeneron Among First Companies in FDA PreCheck Pilot Program | MT |
| Market Cap | 63.44B 331B 55.7B 51.27B 47.77B 90.1B 6,031B 91.93B 617B 239B 2,960B 238B 233B 10,303B | P/E 2026 * |
16.1x | P/E 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise Value | 55.53B 289B 48.75B 44.87B 41.81B 78.86B 5,279B 80.46B 540B 209B 2,591B 208B 204B 9,018B | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 3.01x |
| Free-Float |
72.33% | Yield 2026 * |
0.63% | Yield 2027 * | 0.71% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +2.63% | ||
| 1 week | -0.56% | ||
| Current month | +1.00% | ||
| 1 month | +8.44% | ||
| 3 months | -18.75% | ||
| 6 months | -22.84% | ||
| Current year | -23.02% |
| 1 week | 53.56 |  | 54.95 |
| 1 month | 50.28 | | 55.07 |
| Current year | 50 | | 73.16 |
| 1 year | 48.81 | | 73.33 |
| 3 years | 44.82 | | 111.72 |
| 5 years | 44.82 | | 111.72 |
| 10 years | 18.16 | | 111.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.63% | -0.56% | - | - | 63.44B | |
| -1.56% | +1.14% | +54.57% | +224.32% | 56.98B | |
| +0.36% | +39.60% | +39.60% | +39.60% | 41.58B | |
| +3.16% | +5.65% | -50.57% | -57.33% | 38.01B | |
| -2.66% | +5.90% | +62.50% | -25.95% | 31.9B | |
| +4.98% | +22.16% | +157.27% | -39.37% | 27.79B | |
| +0.96% | +5.89% | +67.10% | +85.00% | 22.65B | |
| -0.56% | +4.05% | +1.53% | +168.92% | 17.64B | |
| +1.34% | -0.64% | +64.17% | +124.88% | 16.49B | |
| -0.22% | +7.34% | +74.03% | +329.11% | 14.59B | |
| Average | +0.77% | +5.98% | +52.24% | +94.35% | 29.74B | |
| Weighted average by Cap. | +0.85% | +5.57% | +48.13% | +82.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.88B 82.78B 13.94B 12.83B 11.96B 22.55B 1,510B 23.01B 154B 59.81B 741B 59.63B 58.34B 2,579B | 17.55B 91.49B 15.41B 14.19B 13.22B 24.93B 1,669B 25.44B 171B 66.1B 819B 65.9B 64.48B 2,851B |
| Net income | 4.09B 21.31B 3.59B 3.3B 3.08B 5.81B 389B 5.92B 39.74B 15.4B 191B 15.35B 15.02B 664B | 5.13B 26.76B 4.51B 4.15B 3.87B 7.29B 488B 7.44B 49.9B 19.33B 240B 19.27B 18.86B 834B |
| Net Debt | -7.91B -41.25B -6.95B -6.4B -5.96B -11.24B -752B -11.47B -76.92B -29.8B -369B -29.71B -29.07B -1,285B | -10.69B -55.7B -9.38B -8.64B -8.05B -15.18B -1,016B -15.48B -104B -40.24B -499B -40.12B -39.25B -1,735B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/07/26 | R$54.59 | +2.63% | 315 |
| 30/06/26 | R$54.05 | -0.46% | 20 |
| 29/06/26 | R$54.30 | -0.55% | 429 |
| 26/06/26 | R$54.60 | +1.94% | 1,726 |
| 25/06/26 | R$53.56 | -2.44% | 85 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
- REGN34 Stock
Select your edition
All financial news and data tailored to specific country editions
